Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

4 days ago
Older men who are obese do not appear to have a lower incidence of fracture compared with their nonobese counterparts, a study has shown in a study.
Audrey Abella, 14 May 2020
The PARP* inhibitor niraparib improves progression-free survival (PFS) and is well-tolerated in women with newly diagnosed advanced ovarian cancer (OCa) after a response to first-line (1L) platinum-based chemotherapy (CT), subgroup results of the phase III PRIMA/ENGOT-OV26/GOG-3012 trial have shown.
5 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.

Highlights from the 13th International Congress of the Asian Society Against Dementia & 6th Singapore International Neuro-Cognitive Symposium

11 Dec 2019
The Schwabe Pharma lunch symposium was held on 30 August 2019, in conjunction with the 13th International Congress of the Asian Society Against Dementia & 6th Singapore International Neuro-Cognitive Symposium. Professor Serge Gauthier and Associate Professor Nagaendran Kandiah were invited as honourable speakers to this symposium to share the latest evidence on the current and potential role of Ginkgo biloba extract (EGb 761®), an anti-dementia agent, in the treatment of dementia and mild cognitive impairment (MCI).
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Singapore digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

4 days ago
Older men who are obese do not appear to have a lower incidence of fracture compared with their nonobese counterparts, a study has shown in a study.
Audrey Abella, 14 May 2020
The PARP* inhibitor niraparib improves progression-free survival (PFS) and is well-tolerated in women with newly diagnosed advanced ovarian cancer (OCa) after a response to first-line (1L) platinum-based chemotherapy (CT), subgroup results of the phase III PRIMA/ENGOT-OV26/GOG-3012 trial have shown.
5 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.